Kidney Transplant
📧 Sign up to get email alerts when something new happens for Kidney Transplant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-02-20Clinical Trial Update: Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients [Phase 1]
Phase 1 study of mycophenolate mofetil (CellCept) in pediatric kidney transplant patients has been terminated.
-
FDA approval · 2013-02-08FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) submitted by Novartis Pharmaceuticals Corporation. The document…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients [Phase 3]
Phase 3 trial comparing sirolimus with cyclosporine in a calcineurin inhibitor-free regimen for kidney transplant recipients was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-26Clinical Trial Update: A Study Of CP-690,550 In Stable Kidney Transplant Patients [Phase 1]
Phase 1 study of CP-690,550 (tofacitinib) in stable kidney transplant patients completed with results posted.
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for mycophenolate mofetil submitted by Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation [NA]
Trial update reporting results from Campath-1H induction in primary kidney transplant recipients and its potential to allow discontinuation …
-
FDA approval · 2012-06-27FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus from Sandoz Inc. The approval enables the marketing of a generic tacrolimus produ…
-
CLINICAL_TRIALS trial_result · 2011-09-14Clinical Trial Update: Cell-mediated Immune Response to Influenza Vaccine
A completed clinical trial evaluated the cell-mediated immune response to the influenza vaccine in kidney transplant recipients.
-
CLINICAL_TRIALS research · 2011-08-04Clinical Trial Update: Prospective Donor Specific Antibody (DSA) Monitoring Protocol
Clinical trial update describing a prospective donor-specific antibody (DSA) monitoring protocol for kidney and kidney/pancreas transplant r…
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab [Phase 4]
Phase 4 trial examining immunophenotyping of peripheral T cells after T cell depletion with alemtuzumab in kidney transplant patients; study…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of enteric-coated mycophenolate sodium (EC-MPS) plus valsartan in de novo kidney transpla…
-
CLINICAL_TRIALS research · 2010-03-26Clinical Trial Update: CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients [Phase 4]
A Phase 4 trial compares dose-adjusted mycophenolate mofetil (CellCept) with fixed-dose standard care in kidney transplant recipients.
-
FDA approval · 2010-01-25FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals Inc., updating the drug's status.
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients. [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating three immunosuppressant regimens in kidney transplant recipients…
-
FDA approval · 2009-05-04FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for mycophenolate mofetil, an immunosuppressant used to prevent organ transplant rejec…
-
FDA approval · 2009-02-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2008-05-15Clinical Trial Update: Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS) [Phase 4]
Phase 4 trial update describing patient-reported outcomes for kidney transplant recipients who were converted to Myfortic (enteric-coated my…
-
CLINICAL_TRIALS research · 2007-04-12Clinical Trial Update: EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function [Phase 3]
Clinical Trial Update for the EXTEND protocol, a Phase 3 study evaluating kidney function in kidney transplant recipients. Current status is…